Futura Medical plc (FUM) Ordinary GBP0.02

Sell:9.04pBuy:10.00p0.42p (4.46%)

Prices delayed by at least 15 minutes
Sell:9.04p
Buy:10.00p
Change:0.42p (4.46%)
Deal now
Prices delayed by at least 15 minutes
Sell:9.04p
Buy:10.00p
Change:0.42p (4.46%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Futura Medical plc is a consumer healthcare company that specializes in the development and global commercialization of sexual health products. The Company is a developer of sexual health products, including the lead product, Eroxon, and two products in development, including WSD4000 and Eroxon Intense. Eroxon is a clear gel used for the treatment of erectile dysfunction (ED) available over the counter and without prescription and addresses significant unmet needs in the ED market. Eroxon Intense provides a potential range extension of the Eroxon product and acts as an additional treatment option for men who have ED. WSD4000 is a topical treatment designed for sexual dysfunction in women. The Company has distribution partners in place in a number of major consumer markets, including Haleon in the United States, and Cooper Consumer Health in Europe.

Key people

Alexander James Hanbury Duggan
Interim Chief Executive Officer
Angela Hildreth
Finance Director, Chief Operating Officer, Company Secretary, Executive Director
Ken W James
Executive Director, Head of R&D
Harmesh Suniara
Non-Executive Director
Roy Davis
Independent Non-Executive Director
Andrew Vaughan Unitt
Senior Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    FUM
  • Location
    United Kingdom
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    GB0033278473
  • Market cap
    £27.34m
  • Employees
    12
  • Shares in issue
    303.70m
  • Exchange
    London Stock Exchange (LON)
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.